Fig. 1
From: Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
Calibration of the risk prediction model of ER-positive tumors (ModelER+), risk prediction model of ER-negative tumors (ModelER-), and Gail risk prediction model (ModelGail) by risk deciles. a ModelER+ in women from the European Prospective Investigation into Cancer and Nutrition (EPIC); b ModelER- in the EPIC women; c ModelER+ in the women from the Women’s Health Initiative (WHI); d ModelER- in the WHI women; e ModelGail in the WHI women